Sanjeev Kumar is a Nephrology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8700 Beverly Blvd
W Hollywood, CA 900481804
Telephone
310-423-2641Provider last certified this registry record 14 Jun 2022.
Clinical trials
- TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)
Sponsor: Centre for Addiction and Mental Health
- Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment
Sponsor: Centre for Addiction and Mental Health
- Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS
Sponsor: Centre for Addiction and Mental Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
- Vertex Pharmaceuticals IncorporatedProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
68.2%Corticosteroid61.5%Prednisone100%Part D≥23 patientsVitamin D3 Analog6.7%Calcitriol100%Part D<11 patientsCancer & immunology
15.6%Calcineurin inhibitor15.6%Tacrolimus100%Part D<11 patientsAnti-infectives
8.9%Azole Antifungal8.9%Fluconazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Switching OFF the Maladaptive Repair Cell State to Halt AKI-to-CKD Progression
Cedars-Sinai Medical Center
FY2026$757,885R01DK146024 - Understanding Epithelial Plasticity in Renal Repair after Acute Kidney Injury
Cedars-Sinai Medical Center
FY2022$382,389R01DK118265 - Understanding Epithelial Plasticity in Renal Repair after Acute Kidney Injury
Cedars-Sinai Medical Center
FY2021$398,139R01DK118265
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”